NCT02869984View on ClinicalTrials.gov

Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 31, 2018

Conditions
Anterior Resection Syndrome
Interventions
DRUG

Ramosetron

Sponsors

Collaborators (1)

Dong-A ST
All Listed Sponsors
collaborator

Dong-A ST

UNKNOWN

lead

Seoul National University Hospital

OTHER